ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates

April 16, 1999

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

White House Agrees To Pay Raise For NCI, NIH, NHLI Chiefs

February 27, 1976

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006